The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-chloro-3-(cyclohexylmethyl)-2-(4-nitrophenyl)-3H-imidazo[4,5-g]quinoline ID: ALA3810340
PubChem CID: 127044561
Max Phase: Preclinical
Molecular Formula: C23H21ClN4O2
Molecular Weight: 420.90
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=[N+]([O-])c1ccc(-c2nc3cc4cccnc4c(Cl)c3n2CC2CCCCC2)cc1
Standard InChI: InChI=1S/C23H21ClN4O2/c24-20-21-17(7-4-12-25-21)13-19-22(20)27(14-15-5-2-1-3-6-15)23(26-19)16-8-10-18(11-9-16)28(29)30/h4,7-13,15H,1-3,5-6,14H2
Standard InChI Key: NXPULCNSBKAYRL-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
4.6043 -0.6682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6043 0.8382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3044 1.5915 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3044 -1.4214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9924 -0.6682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9924 0.8382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7168 1.5915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7168 -1.4214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5831 -0.6682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5831 0.8382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0045 1.2999 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8792 0.0850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0045 -1.1298 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.3799 0.0850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2183 1.3232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.7144 1.2150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.3687 -0.1348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5270 -1.3763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0309 -1.2682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7217 2.7914 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.4731 2.7230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9422 3.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4134 4.4543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.8823 4.7583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.8800 3.6382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4088 2.2141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9400 1.9101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.8655 -0.2461 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-9.5406 0.7460 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-9.3874 -1.3266 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 9 1 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
7 20 1 0
11 21 1 0
21 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
17 28 1 0
28 29 1 0
28 30 2 0
M CHG 2 28 1 29 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 420.90Molecular Weight (Monoisotopic): 420.1353AlogP: 6.39#Rotatable Bonds: 4Polar Surface Area: 73.85Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.54CX LogP: 6.32CX LogD: 6.32Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.28Np Likeness Score: -1.27
References 1. Carta A, Briguglio I, Piras S, Corona P, Ibba R, Laurini E, Fermeglia M, Pricl S, Desideri N, Atzori EM, La Colla P, Collu G, Delogu I, Loddo R.. (2016) A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems., 117 [PMID:27161176 ] [10.1016/j.ejmech.2016.03.080 ]